Clinical Trial Update: Mesenchymal Stem Cells After Renal or Liver Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stem cells as an adjunct therapy after renal or liver transplantation completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure
• Liver Failure

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Liege | Conditions: Liver Failure, Kidney Failure | Phase 1, Phase 2 | Status: COMPLETED